These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19420351)

  • 1. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.
    Morris TA; Marsh JJ; Chiles PG; Magaña MM; Liang NC; Soler X; Desantis DJ; Ngo D; Woods VL
    Blood; 2009 Aug; 114(9):1929-36. PubMed ID: 19420351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
    Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
    PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure.
    Marsh JJ; Chiles PG; Liang NC; Morris TA
    Thromb Res; 2013; 132(6):729-34. PubMed ID: 24182551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Goldsmith K; van Marion V; Long L; Treacy CM; Dudbridge F; Toshner MR; Pepke-Zaba J; Eikenboom JC; Morrell NW
    Eur Respir J; 2008 Apr; 31(4):736-41. PubMed ID: 18057060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Yaoita N; Satoh K; Satoh T; Shimizu T; Saito S; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Kikuchi N; Kurosawa R; Miyata S; Nagasaki M; Yasuda J; Shimokawa H
    J Am Heart Assoc; 2020 Nov; 9(21):e015902. PubMed ID: 33103541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
    Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
    J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Dodson MW; Allen-Brady K; Brown LM; Elliott CG; Cannon-Albright LA
    Chest; 2019 Feb; 155(2):384-390. PubMed ID: 30732691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
    Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P
    Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.
    Jan K; Pavel J; Renata C; Daniela D; Petra B; Martin Š; Zuzana Z; Tomáš K
    Clin Appl Thromb Hemost; 2024; 30():10760296241271369. PubMed ID: 39150410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Clinical Characteristics of Heterozygous
    Kiko T; Asano R; Ishibashi T; Endo H; Nishi N; Hayashi H; Ueda J; Aoki T; Tsuji A; Nakaoka Y; Ogo T
    J Am Heart Assoc; 2024 Aug; 13(15):e035009. PubMed ID: 39056331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Research in Chronic Thromboembolic Pulmonary Hypertension.
    Opitz I; Kirschner MB
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
    Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T
    Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.
    Guérin L; Couturaud F; Parent F; Revel MP; Gillaizeau F; Planquette B; Pontal D; Guégan M; Simonneau G; Meyer G; Sanchez O
    Thromb Haemost; 2014 Sep; 112(3):598-605. PubMed ID: 24898545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age.
    Ramanathan R; Gram J; Feddersen S; Nybo M; Larsen A; Sidelmann JJ
    Scand J Clin Lab Invest; 2013 Oct; 73(7):585-90. PubMed ID: 24000886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
    Bohacekova M; Kaldararova M; Valkovicova T; Remkova A; Vesely J; Simkova I
    Bratisl Lek Listy; 2016; 117(10):577-582. PubMed ID: 27826972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
    Wong CL; Szydlo R; Gibbs S; Laffan M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.